Ingredion (NYSE:INGR) Price Target Raised to $173.00 at UBS Group

Ingredion (NYSE:INGR - Get Free Report) had its price objective hoisted by investment analysts at UBS Group from $165.00 to $173.00 in a report issued on Friday,Benzinga reports. The firm presently has a "buy" rating on the stock. UBS Group's price target points to a potential upside of 22.88% from the company's previous close.

Other equities analysts also recently issued research reports about the stock. Oppenheimer boosted their target price on shares of Ingredion from $147.00 to $178.00 and gave the stock an "outperform" rating in a report on Wednesday, November 6th. StockNews.com downgraded shares of Ingredion from a "strong-buy" rating to a "buy" rating in a research note on Wednesday, August 7th. BMO Capital Markets upped their price target on shares of Ingredion from $128.00 to $147.00 and gave the company a "market perform" rating in a research note on Wednesday, November 6th. Finally, Barclays upped their price target on shares of Ingredion from $145.00 to $168.00 and gave the company an "overweight" rating in a research note on Wednesday, November 6th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $155.17.

Ingredion Price Performance

Shares of INGR traded down $8.40 during mid-day trading on Friday, reaching $140.79. The stock had a trading volume of 955,173 shares, compared to its average volume of 384,053. Ingredion has a 12 month low of $100.90 and a 12 month high of $155.44. The business has a fifty day moving average of $137.44 and a 200 day moving average of $126.35. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.69 and a current ratio of 2.67. The firm has a market cap of $9.17 billion, a price-to-earnings ratio of 13.74, a PEG ratio of 1.29 and a beta of 0.73.

Ingredion (NYSE:INGR - Get Free Report) last released its earnings results on Tuesday, November 5th. The company reported $3.05 EPS for the quarter, topping the consensus estimate of $2.58 by $0.47. Ingredion had a net margin of 9.05% and a return on equity of 17.75%. The firm had revenue of $1.87 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same quarter in the previous year, the firm earned $2.33 earnings per share. The company's quarterly revenue was down 8.0% compared to the same quarter last year. Equities analysts predict that Ingredion will post 10.6 EPS for the current year.

Insider Buying and Selling at Ingredion

In other Ingredion news, CEO James P. Zallie sold 1,300 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $134.03, for a total transaction of $174,239.00. Following the transaction, the chief executive officer now directly owns 52,530 shares in the company, valued at $7,040,595.90. This represents a 2.42 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Larry Fernandes sold 4,700 shares of the stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $153.41, for a total transaction of $721,027.00. Following the transaction, the senior vice president now owns 29,034 shares in the company, valued at approximately $4,454,105.94. The trade was a 13.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 30,056 shares of company stock worth $4,121,736 over the last quarter. Insiders own 1.80% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP lifted its position in shares of Ingredion by 4.9% during the second quarter. Dimensional Fund Advisors LP now owns 2,685,339 shares of the company's stock valued at $308,009,000 after buying an additional 125,543 shares during the last quarter. State Street Corp lifted its position in shares of Ingredion by 0.8% during the third quarter. State Street Corp now owns 2,436,601 shares of the company's stock valued at $334,862,000 after buying an additional 19,560 shares during the last quarter. Pacer Advisors Inc. lifted its position in shares of Ingredion by 92.4% during the second quarter. Pacer Advisors Inc. now owns 1,764,012 shares of the company's stock valued at $202,332,000 after buying an additional 846,967 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in shares of Ingredion by 2.4% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,539,179 shares of the company's stock valued at $211,529,000 after buying an additional 36,421 shares during the last quarter. Finally, Cooke & Bieler LP lifted its position in shares of Ingredion by 2.7% during the second quarter. Cooke & Bieler LP now owns 1,018,002 shares of the company's stock valued at $116,765,000 after buying an additional 27,087 shares during the last quarter. 85.27% of the stock is currently owned by institutional investors.

Ingredion Company Profile

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.